---
title: "Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290867314.md"
description: "Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generation"
datetime: "2026-06-25T18:15:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290867314.md)
  - [en](https://longbridge.com/en/news/290867314.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290867314.md)
generator: "portal-rs"
---

# Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generation


### Related Stocks

- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)

## Related News & Research

- [ONCO: Q2 2026 revenue up 62% YoY, with strong margins and EMA review for label expansion ongoing](https://longbridge.com/en/news/297137606.md)
- [Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Foundation for Biomarker-Driven Cancer Therapy](https://longbridge.com/en/news/296130343.md)
- [VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase](https://longbridge.com/en/news/296932909.md)
- [AI turns up a promising finding in cancer data that researchers hadn’t noticed for years](https://longbridge.com/en/news/297215988.md)
- [HAMLET.B: Advanced cancer and infection therapies reached Phase III, supported by strong R&D and financing](https://longbridge.com/en/news/297278926.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**